Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

206.64 +0.75 (+0.36%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Revolution Medicines, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development ↗

December 15, 2023

These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better.

Via InvestorPlace

3 Biotech Stocks That Could Boom or Bust by 2025 ↗

November 16, 2023

Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday.

Via InvestorPlace

Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details ↗

November 16, 2023

Raymond James initiated coverage on Revolution Medicines Inc (NASDAQ: RVMD), noting that the October readout of RMC-6236 was compelling compared to historical SoC.

Via Benzinga

What 6 Analyst Ratings Have To Say About Revolution Medicines ↗

November 07, 2023

Via Benzinga

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

Preview: Revolution Medicines's Earnings ↗

November 03, 2023

Via Benzinga

Crude Oil Falls Sharply; Apollomics Shares Plunge ↗

October 23, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded down 0.19% to 33,062.85 while the NASDAQ rose 0.80% to 13,088.09. The S&P...

Via Benzinga

Topics Stocks

Why Revolution Medicines Stock Is Crashing Today ↗

October 23, 2023

Investors were disappointed by Revolution Medicines' data, presented at ESMO.

Via The Motley Fool

Expert Ratings for Revolution Medicines ↗

October 12, 2023

Via Benzinga

Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 23, 2023

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 23, 2023

Via Benzinga

Nasdaq Turns Higher; Akumin Shares Jump ↗

October 23, 2023

U.S. stocks pared losses midway through trading, with the Nasdaq Composite gaining over 60 points on Monday. The Dow traded down 0.01% to 33,126.50 while the NASDAQ rose 0.54% to 13,054.00. The S&P 500...

Via Benzinga

Topics Stocks

Stifel Maintains Buy Rating for Revolution Medicines: Here's What You Need To Know ↗

September 21, 2023

Via Benzinga

Analyst Ratings for Revolution Medicines ↗

August 09, 2023

Via Benzinga

Revolution Medicines Earnings Preview ↗

August 07, 2023

Via Benzinga

FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday ↗

October 23, 2023

U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Revolution Medicines Crashes 39% On Lackluster Test Results In Cancer Treatment ↗

October 23, 2023

The results were "at best, in line" with expectations for lung and pancreatic cancer treatment.

Via Investor's Business Daily

Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September ↗

October 23, 2023

U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, The Dow traded down 0.41% to 32,991.58 while the NASDAQ fell...

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 23, 2023

Via Benzinga

Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90 ↗

October 16, 2023

Revolution Medicines shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday ↗

October 16, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s session.

Via Benzinga

Topics Stocks

Why Shares of Revolution Medicines Were Popping on Friday ↗

October 13, 2023

The company released positive phase 1/1b trial data on two cancer therapies.

Via The Motley Fool

Why Is Cancer Focused Revolution Medicines Stock Trading Higher Today? ↗

October 13, 2023

Revolution Medicines Inc (NASDAQ: RVMD) released preliminary data for RMC-6236, its RASMULTI(ON) Inhibitor, and RMC-6291, its RASG12C(ON) Inhibitor, from the

Via Benzinga

Top 4 Health Care Stocks That Are Preparing To Pump This Quarter ↗

October 06, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

September 21, 2023

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID), EQRx, Inc. (Nasdaq - EQRX)

August 10, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Top 5 Health Care Stocks That May Crash In Q3 ↗

August 07, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 01, 2023

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 01, 2023

Via Benzinga

Revolution Medicines To Acquire EQRx In All-Stock Transaction To Gain Over $1B In Additional Capital ↗

August 01, 2023

Revolution Medicines Inc (NASDAQ: RVMD) has agreed to acquire EQRx Inc (NASDAQ: EQRX) in an all-stock transaction intended to add more than $1 billion in net cash to

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.